HER2 MUTATION
Clinical trials for HER2 MUTATION explained in plain language.
Never miss a new study
Get alerted when new HER2 MUTATION trials appear
Sign up with your email to follow new studies for HER2 MUTATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New pill targets HER2 cancers in phase 2 trial
Disease control Recruiting nowThis study tests an oral drug called BAY 2927088 in people with advanced solid tumors that have HER2 mutations. The drug aims to block the abnormal HER2 protein and stop cancer growth. About 111 adults with various cancers (excluding lung cancer) will take the drug daily until th…
Matched conditions: HER2 MUTATION
Phase: PHASE2 • Sponsor: Bayer • Aim: Disease control
Last updated May 26, 2026 06:22 UTC
-
New pill could outshine standard care for HER2 lung cancer
Disease control Recruiting nowThis study tests a new daily pill, sevabertinib, against standard intravenous chemotherapy for people with advanced non-small cell lung cancer that has specific HER2 mutations. About 444 adults will take either the pill or standard treatment. The goal is to see if the pill delays…
Matched conditions: HER2 MUTATION
Phase: PHASE3 • Sponsor: Bayer • Aim: Disease control
Last updated May 26, 2026 06:17 UTC